US Patent 7405241 Use of N
Patent 7405241 was granted and assigned to Air Liquide on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
A medicinal composition and method to treat or minimize post-ischemic brain cell deterioration that comprises nitrous oxide or a nitrous oxide donor and xenon or a xenon donor. The medicinal composition may be administered prior to or subsequent to a stroke.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07405241 Use of N US Patent 7405241 Use of N
Infobox
Patent Number
0740524100
Patent Number
740524100
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074052410
Date of Patent
July 29, 2008
0Patent Application Number
107585130
Date Filed
January 15, 2004
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074052410
Date of Patent
July 29, 2008
0Patent Application Number
107585130
Date Filed
January 15, 2004
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07405241 Use of N
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07405241
Date of patent
July 29, 2008
Patent application number
10758513
Date Filed
January 15, 2004
Patent primary examiner
Find more entities like US Patent 7405241 Use of N
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.